IPO: Relay Therapeutics Plans To Use Big Data For Drug Discovery

IPO: Relay Therapeutics Plans To Use Big Data For Drug Discovery

Relay Therapeutics is a clinical-stage precision medicines company innovating in the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The company leverages insights into protein motion and how this dynamic behavior relates to protein function. These insights may enable Relay to more effectively drug protein targets that … Read more

Categories IPO

How A Secular Trend In Adoption Of IoT Devices Is Powering A Replatforming Of Medicine Using Bioinformatics

How A Secular Trend In Adoption Of IoT Devices Is Powering A Replatforming Of Medicine Using Bioinformatics

The continued adoption of Internet-related equipment, devices, and services in the health industry is expected to drive the market to reach nearly $200 billion by 2024 according to a new report prepared by Laura Wood at Research and Markets. By the end of 2020, it is estimated that there will be 21 billion connected devices … Read more

The Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance Takes On COVID-19

The Armed Forces Health Surveillance Branch’s Global Emerging Infections Surveillance Takes On COVID-19

Genetic sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), has played a critical role in the public health response, including in the design of diagnostics and vaccines. Within the Department of Defense, SARS-CoV-2 genetic sequence data plays a vital role in force health protection efforts. … Read more

Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Legal Dispute Threatens Production Of Promising COVID Vaccine

Inovio Pharmaceuticals filed suit against VGXI, a subsidiary of South Korea’s GeneOne Life Sciences, last month, accusing it of not transferring technical details pertaining to manufacturing doses of INO-4800, Inovio’s DNA vaccine compound with promising results against SARS-CoV-2. Inovio details in the lawsuit that VGXI does not possess the capacity to scale up manufacturing, which is essential … Read more

Berkeley Lights Sets IPO For Its Single Cell Manipulation Platform

The Emeryville, CA-based company will offer 7.4 million shares to raise $126 million at $16 to $18 per share, which translates into a fully diluted market value of $1.2 billion. Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. … Read more

Categories IPO

This Startup Is Innovating In Protein Sythesizers

This Startup Is Innovating In Protein Sythesizers

Protein synthesizers speed up the production of enzymes, therapeutics and lab reagents. Toronto-based Liberumbio’s product use proprietary molecular and hardware technology, enabling biological manufacturer to bring speed, scalability and to reduce cost to protein synthesis. The market size of recombinant proteins today is $119 billion. But it’s expected to reach $400 billion just by 2025. … Read more

Meet IndieBio’s San Francisco Class 10 And New York Class 1

Meet IndieBio’s San Francisco Class 10 And New York Class 1

IndieBio announced its new batches of startups in June. The life sciences startup incubator allocates each team $250,000 in seed funding plus lab and co-working space and dedicated mentorship. Afterwards, each company becomes part of a network of IndieBio alumni, investors, and biotech entrepreneurs. This is New York’s first batch, and San Francisco’s tenth. Though … Read more